Pakistan 2009 (n=109 ) Partin 2007* (n= 5730 )
CLINICAL STAGE    
T1c 33 (30) 4419 (77)
T2a 25 (23) 998(17)
T2b/T2c 51 (47) 313 (6)
PSA (ng/ml) Δ    
0-2.5 3 (3) 452 (8)
2.6-4.0 2 (2) 946 (17)
4.1-6.0 15 (14) 1994 (35)
6.1-10.0 34 (31) 1671 (29)
>10.0 55 ( 50) 667 (12)
BIOPSY GLEASON SUM    
5-6 63 (58) 4402 (77)
3+4=7 23 (21) 816 (14)
4+3=7 11 (10) 348 (6)
8-10 12 ( 11) 164 (3)
PATHOLOGICAL STAGE    
Organ confined 63 (58) 4204 (73)
Extra prostatic extension 9 (8) 1276 (22)
Seminal vesicle involvement 24 (22) 180 (3)
Lymph node metastasis 13 (12) 70 (1)
*  Makarov et al. [13] Δ Abbot Hybritech Assay
Table 1: Comparison of Clinical and pathological features